Covance Inc $83.18

up +0.28


2/9/2014 03:30 PM  |  NYSE : CVD  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get CVD Trend Analysis - it has underperformed the S&P 500 by 22%

Partner Headlines

  1. Contract Researcher Parexel Sees Growth In Biotech

    IBD
  2. WuXi Leverages China's Drug Strength As Outsourcer

    IBD
  3. Morgan Stanley Sees Improving Early Stage for Covance

    Benzinga
  4. Covance Board Authorizes $100M Stock Buyback

    Benzinga
  5. Covance NeoGenomics Enter Strategic Alliance for Anatomic Pathology and ...

    Benzinga
  6. Parexel Plunges After 3 CROs Report Earnings

    IBD
  7. FBN at the Forbes Healthcare Summit

    FoxBusiness
  8. Covance Announces $250M Long-Term Private Placement Debt Financing

    Benzinga
  9. Parexel Stock Rises As Analyst Upgrades, Touts CROs

    IBD
  10. Benzinga's Top Initiations

    Benzinga
  11. Medical Research Firms Tap Drug Development Trend

    IBD
  12. Medical Research Firms Tap Drug Development Trend

    IBD
  13. Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells ...

    GuruFocus
  14. Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc. ...

    GuruFocus
  15. Benzinga's Top Downgrades

    Benzinga
  16. UPDATE: ISI Group Reiterates Neutral Rating, Raises PT on Covance

    Benzinga
  17. UPDATE: Jefferies Reiterates Hold Rating, Raises PT on Covance

    Benzinga
  18. UPDATE: J.P. Morgan Reiterates Overweight Rating, Raises PT on Covance

    Benzinga
  19. UPDATE: Sterne Agee Reiterates Buy Rating, Raises PT on Covance

    Benzinga
  20. Top Narrow Based Indexes For January 14, 2013

    Benzinga
  21. Four European Stocks Worth a Look Now (DLPH, ICLR, IR, LYB)

    Benzinga
  22. Covance, Inc. (CVD) Chairman and CEO Joseph L Herring sells 40,800 Shares

    GuruFocus
  23. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With ...

    Benzinga
  24. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With ...

    Benzinga
  25. Covance Inc. Reports Operating Results (10-K)

    GuruFocus
  26. Stocks Fall As Greek Talks Hit Another Bump With CF Industries (CF) and ...

    MarketIntelligenceCenter
  27. UPDATE: Citigroup Downgrades Covance to Neutral

    Benzinga
  28. Stocks Give Back Early Gains With Hess (HES) and Toll Brothers (TOL) on ...

    MarketIntelligenceCenter
  29. UPDATE: Goldman Sachs Downgrades Covance to Neutral

    Benzinga
  30. Goldman Sachs Downgrades Covance to Neutral

    Benzinga
  31. Covance Board Authorizes $300M Stock Buyback

    Benzinga
  32. Biotechs, HMOs, Digital Records Push Aid Health Stocks

    IBD
  33. UPDATE: Citigroup Maintains Buy, Lowers PT to $55 on Covance

    Benzinga
  34. Stocks Mixed at Midday with Research in Motion (RIMM) and Walgreen (WAG) ...

    MarketIntelligenceCenter
  35. Jefferies Lowers PT on Covance to $44

    Benzinga
  36. Covance Reiterates Full Year 2011 Revenue and Pro Forma EPS

    Benzinga
Trading Center